Is Medigen Vaccine Biologics stock a buy?
What Is The Conclusion?
Right now our advanced algorithms say:
Do the analyst corps agree?
Interesting Questions and Easy Answers!
We cannot find any recorded dividends paid in our systems.
Sorry, we do not have any analyst data for this ticker
We cannot find data for Medigen Vaccine Biologics 10 years ago, but if you had invested on Tuesday 10th of September 2019 when the price was TWD18.60, you would have made a profit of TWD29.00 per share or 155.89%
Yes, the average daily trading liquidity for Medigen Vaccine Biologics is TWD1.25 million. You should therefore be able to get in and out of your positions relatively fast.
Medigen Vaccine Biologics has a normal ratio of the business financed by loans. This puts the company at some risk in periods of high inflation where borrowing costs usually go up. The company is still not profitable, and high inflation will make it harder to become profitable as costs increase and consumer spending decreases.
We have calculated the inflation risk for Medigen Vaccine Biologics to be high [0.85 of 1]
US inflation for July 2024 was 0.15%. Over the last 12 months, the US inflation is 2.92%. The 10-year treasury yield that indicates the future interest level is currently 3.72 and is down -0.95 over the last 30 days.